Labs vs AvcnCan someone explain why Avicanna is doing so well with only 3.3 millions of revenue in Qrt 2. Avicanna stock double in 1 month and we still stand at $0,08 zip no mouvement for Labs. Something is wrong here, investors haven't still digest the last 3 years bad call by the early management or what. We can talk about stock manipulation but the retail investors are still very cold on Labs even the promising future this is really a wait and see period as far as i am concern.